ATS

Presented at ATS 2019:

• This study has shown there is a relatively linear association of airway pressures with increase in gas flow when using the device over the gas flows investigated.
• The VersaPAP* device could be considered to provide short-term positive pressure support to a patient if there was no direct access to the use of non-invasive mechanical ventilation.

Download poster

Presented at ATS 2019:

Presented at ATS 2019:

• The experiments reported in this study should caution practitioners regarding the interchangeability of OPEP and aerosol delivery devices.
• The findings reinforce that data obtained with one combination of devices cannot be extrapolated to other devices, as performance variation can occur.

Download poster

Presented at ATS 2019:

• The MC 300* nebulizer offers the clinician additional choice when short treatment times and maximizing respirable dose are a priority.

Download poster

Presented at ATS 2019:

• Based on these laboratory data, the VHC with tracheostomy adaptor appears to provide a reliable means of delivering SMI aerosols to patients with a tracheostomy tube or tracheal stoma.
• Further research is required to determine the clinical relevance of these in vitro findings.

Download poster

This laboratory-based study compared the behavior of widely prescribed large and small volume VHCs for the delivery of Pressurized Metered Dose Inhaler (pMDI)-delivered Fluticasone Propionate (FP).

Download poster

This study compared a continuous jet nebulizer (MMC Continuous, in development), with other continuous jet nebulizers available in the USA.

Download poster